dude, you need to google Genisgnia. It says in plain english on their site that Antonius Schuh and the trov gang are the officers of that company too.
i trade ARIA and its a pretty good trading stock. it will pull back to the low 7s/upper 6s and then pop up to the high 8s low 9s. it will probably get to the 10-15 range in 6-8mos so its a fun one.
Shares of molecular diagnostic company Myriad Genetics (MYGN) are climbing after the company reported second quarter results that beat consensus expectations, raised its fiscal 2014 outlook, and announced an acquisition. WHAT'S NEW: Last night, Myriad Genetics reported second quarter earnings per share of 66c and revenue of $204.1M, easily topping analysts' consensus expectations of 46c and $176.02M, respectively. The company raised its FY14 EPS view to $2.09-$2.14 from $1.92-$1.97, and boosted its FY14 revenue outlook to $740M-$750M from $700M-$715M. FY14 consensus estimates were $1.97 and $705.62M prior to the company's announcement. In addition, the company said it has a definitive agreement to acquire rival Crescendo Bioscience for $270M in cash. ANALYST REACTION: This morning, analyst commentary was mixed. Research firm JMP Securities upgraded Myriad Genetics to Market Perform from Underperform citing the company’s stronger than expected results. Conversely, Ladenburg downgraded Myriad to Neutral from Buy, citing valuation. PRICE ACTION: In late morning trading, Myriad rose $2.72, or 10%, to $29.90 on more than twice its average daily trading volume. The stock is up about 10% over the past twelve months. OTHERS TO WATCH: Myriad’s competitors include Sequenom (SQNM), TrovaGene (TROV), and Genomic Health (GHDX).
go do some more research about time decay on out of the money options
do yall realize that options ex was last fri? you may consider not trading options if you dont know how they work.
i dont know for sure but i think its people going long here. i hope things are starting to heat up.
yep, edgex has 120 on the bid at 5.50. there's been some size on the bid the past few days.